News
Zacks Investment Research on MSN8h
Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line GrowthPfizer PFE reported second-quarter 2025 adjusted earnings per share of 78 cents, which comprehensively beat the Zacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback